Combined treatment with immunoadsorption and rituximab leads to fast and prolonged clinical remission in difficult-to-treat pemphigus vulgaris

Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis

(2011) M. H. Buch et al.   ANNALS OF THE RHEUMATIC DISEASES

A systematic review of randomized controlled trials for pemphigus vulgaris and pemphigus foliaceus

(2011) Linda K. Martin et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Immunoadsorption in dermatology

(2010) Enno Schmidt et al.   ARCHIVES OF DERMATOLOGICAL RESEARCH

Rituximab in Severe Pemphigus

(2009) Enno Schmidt et al.   Annals of the New York Academy of Sciences

Reliability and Convergent Validity of Two Outcome Instruments for Pemphigus

(2009) Misha Rosenbach et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

B-cell-directed therapies for autoimmune disease

(2009) Thomas Dörner et al.   Nature Reviews Rheumatology

Clinical and Immunological Follow-Up of Pemphigus Patients on Adjuvant Treatment with Immunoadsorption or Rituximab

(2008) Martin Pfütze et al.   DERMATOLOGY

Recommendations for the use of rituximab (anti-CD20 antibody) in the treatment of autoimmune bullous skin diseases

(2008) Michael Hertl et al.   JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT

Rituximab Exerts a Dual Effect in Pemphigus Vulgaris

(2008) Rüdiger Eming et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus

(2008) Dedee F. Murrell et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Anti-desmoglein IgG autoantibodies in patients with pemphigus in remission

(2008) EJ Kwon et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY